Loss of BRCA1 expression in sporadic male breast carcinoma Xiaoping SunYun GongSunil Badve OriginalPaper Pages: 1 - 7
Inhibition of myc-dependent breast tumor formation in transgenic mice Wei CuiBarry A. GustersonA. John Clark OriginalPaper Pages: 9 - 20
Involvement of breast epithelial-stromal interactions in the regulation of protein tyrosine phosphatase-γ (PTPγ) mRNA expression by estrogenically active agents Suling LiuSamuel K. KulpYoung C. Lin OriginalPaper Pages: 21 - 35
Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells T. KieferP. T. RamS. M. Hill OriginalPaper Pages: 37 - 45
Dominant negative interference of transcription factor AP-2 causes inhibition of ErbB-3 expression and suppresses malignant cell growth Chun-Hong ZhuFrederick E. Domann OriginalPaper Pages: 47 - 57
Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case-controls study Annette Pernille HøyerAnne-Marie GerdesHelle Bøggild Hartvig OriginalPaper Pages: 59 - 65
Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer Shinichi TsutsuiShinji OhnoShinya Oda OriginalPaper Pages: 67 - 75
Overexpression of MDM2 oncoprotein correlates with possession of estrogen receptor alpha and lack of MDM2 mRNA splice variants in human breast cancer Masao HoriJiro ShimazakiMitsuo Hori OriginalPaper Pages: 77 - 84
Preservation of histopathologic assessment by use of a special technique for tissue inactivation by radiofrequency Sylvia H. Heywang-KöbrunnerWieland WeiwadJörg Buchmann OriginalPaper Pages: 85 - 88